🇺🇸 FDA
Pipeline program

Intensive BP control

2016CXGC07

Unknown small_molecule active

Quick answer

Intensive BP control for Primary Hypertension is a Unknown program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese University of Hong Kong
Indication
Primary Hypertension
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials